Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Darexaban SCHEMBL2227024 | 1.00 | F10 (1.00) | F10KLKB1 | |
| Darexaban SCHEMBL5406349 | 0.95 | F10 (0.90) | F10KLKB1 | |
| SCHEMBL9979807 | 0.90 | F10 (1.00) | F10KLKB1 | |
| SCHEMBL9940055 | 0.90 | F10 (0.82) | F10KLKB1 | |
| SCHEMBL9979802 | 0.90 | F10 (0.81) | F10KLKB1 | |
| SCHEMBL5410384 | 0.89 | F10 (0.81) | F10KLKB1 | |
| Hydrochloric Acid SCHEMBL5393248 | 0.89 | F10 (0.98) | F10KLKB1 | |
| SCHEMBL9979811 | 0.89 | F10 (1.00) | F10KLKB1 | |
| SCHEMBL9979766 | 0.89 | F10 (1.00) | F10KLKB1 | |
| SCHEMBL9979758 | 0.89 | F10 (1.00) | F10KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7307074-B2 | Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration | ASTELLAS PHARMA INC. (JP) | 2007-12-11 | — | — | US | claimed |
| US-RE43481-E1 | Diazepan derivatives or salts thereof | ASTELLAS PHARMA INC. (JP) | 2012-06-19 | — | — | US | disclosed |
| EP-2343076-A1 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | Astellas Pharma Inc. (JP) | 2011-07-13 | — | — | EP | disclosed |
| US-7307074-B2 | Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration | ASTELLAS PHARMA INC. (JP) | 2007-12-11 | — | — | US | disclosed |
| US-7307074-B2 | Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration | ASTELLAS PHARMA INC. (JP) | 2007-12-11 | — | — | US | disclosed |